| http://www.w3.org/ns/prov#value | - The first draft guidance provided recommendations for industry on the submission of protocol information to the Clinical Trials Data Bank.[3] It included information about the types of clinical trials for which submissions are required under section 113 of the Modernization Act, as well as the content of those submissions.The second draft guidance addressed procedural issues, including how to subm
|
